Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous fibrin glue versus saline after FESS for bilateral sinonasal polyps
IRCT20180217038763N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2022
- Modality
- Peripheral Blood HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, single-blind trial of autologous fibrin glue in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Improvement of sinonasal polyposis symptoms after FESS surgery, Amelioration of surgical bed tissues and 1 more. Started Apr 2022; status: completed.
02
Drugs
autologous fibrin glue
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20180217038763N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180217038763N4.